Matches in Wikidata for { <http://www.wikidata.org/entity/Q61651658> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q61651658 description "article scientifique publié en 2003" @default.
- Q61651658 description "artículu científicu espublizáu n'ochobre de 2003" @default.
- Q61651658 description "im Oktober 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61651658 description "scientific article published on 01 October 2003" @default.
- Q61651658 description "wetenschappelijk artikel" @default.
- Q61651658 description "наукова стаття, опублікована в жовтні 2003" @default.
- Q61651658 description "مقالة علمية تنشرت ف 1 أكتوبر 2003" @default.
- Q61651658 name "T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don" @default.
- Q61651658 name "T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don" @default.
- Q61651658 type Item @default.
- Q61651658 label "T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don" @default.
- Q61651658 label "T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don" @default.
- Q61651658 prefLabel "T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don" @default.
- Q61651658 prefLabel "T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don" @default.
- Q61651658 P1433 Q61651658-640B5C9C-22A7-475A-94D9-A470BA6D30AB @default.
- Q61651658 P1476 Q61651658-CDEF0FC2-BDF3-4336-9B14-E416709822D0 @default.
- Q61651658 P2093 Q61651658-0FC29471-E850-40B2-AA89-3A46DD5DC22A @default.
- Q61651658 P2093 Q61651658-11819452-4FBB-4CC1-829F-257D29F17DBD @default.
- Q61651658 P2093 Q61651658-3745A4EA-653B-4AB8-9E37-62CF34134AF3 @default.
- Q61651658 P2093 Q61651658-ACDD344C-A75E-4886-AAEB-CF415FF8498C @default.
- Q61651658 P2093 Q61651658-BE383E37-5076-4ACA-B458-CDE8ADB6CB66 @default.
- Q61651658 P2093 Q61651658-D7BED89A-792B-4F88-8A69-3FFD09CAEF75 @default.
- Q61651658 P304 Q61651658-D715264D-A7E6-4A8E-B44D-D72C4E7E5669 @default.
- Q61651658 P31 Q61651658-529A7509-CB7D-4778-AA42-B47BF0BB7FBD @default.
- Q61651658 P356 Q61651658-81E26A79-E9C6-4141-AF32-73D0AEE96B29 @default.
- Q61651658 P407 Q61651658-661BF830-DE64-4C80-858A-FFEB3DC3ACF3 @default.
- Q61651658 P433 Q61651658-DAECA9AD-9684-4415-8677-A5FEE6124DCD @default.
- Q61651658 P478 Q61651658-9B4F76B8-4E0B-477C-BD90-5487F0F122B0 @default.
- Q61651658 P50 Q61651658-1BAEC217-DA93-48AB-B9AA-C647DEDBDD6D @default.
- Q61651658 P50 Q61651658-7EEC3899-E99D-41CE-BDE3-7E89DB5D62A7 @default.
- Q61651658 P50 Q61651658-C1417E5B-A797-4735-BB98-EF793D3320BA @default.
- Q61651658 P50 Q61651658-CE7F1F35-CDF7-4A04-BDAD-B79098B87CD2 @default.
- Q61651658 P50 Q61651658-EB83D62A-68B5-48AB-B415-8F4674F55DB5 @default.
- Q61651658 P50 Q61651658-F4FE6076-DF91-49F5-B225-9633DFC31D38 @default.
- Q61651658 P577 Q61651658-BF222A71-205D-41B2-95ED-21CAC612D7BD @default.
- Q61651658 P698 Q61651658-25CC0437-DEED-4FE9-853E-D1D30B743817 @default.
- Q61651658 P921 Q61651658-58ED50B5-587A-41A5-9C15-76030B2E1047 @default.
- Q61651658 P921 Q61651658-7471DF2A-8B59-4131-9BCD-E38D04CA5B07 @default.
- Q61651658 P356 J.1365-2141.2003.04612.X @default.
- Q61651658 P698 14531914 @default.
- Q61651658 P1433 Q4970200 @default.
- Q61651658 P1476 "T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions" @default.
- Q61651658 P2093 "Dharsha Thuraisundaram" @default.
- Q61651658 P2093 "Karl Peggs" @default.
- Q61651658 P2093 "Kwee Yong" @default.
- Q61651658 P2093 "Michael Watts" @default.
- Q61651658 P2093 "Stephanie Verfuerth" @default.
- Q61651658 P2093 "Stephen Mackinnon" @default.
- Q61651658 P304 "309-322" @default.
- Q61651658 P31 Q13442814 @default.
- Q61651658 P356 "10.1046/J.1365-2141.2003.04612.X" @default.
- Q61651658 P407 Q1860 @default.
- Q61651658 P433 "2" @default.
- Q61651658 P478 "123" @default.
- Q61651658 P50 Q109927200 @default.
- Q61651658 P50 Q110167848 @default.
- Q61651658 P50 Q110168886 @default.
- Q61651658 P50 Q46227021 @default.
- Q61651658 P50 Q5740316 @default.
- Q61651658 P50 Q59662258 @default.
- Q61651658 P577 "2003-10-01T00:00:00Z" @default.
- Q61651658 P698 "14531914" @default.
- Q61651658 P921 Q467635 @default.
- Q61651658 P921 Q65592366 @default.